0 Comments
0 Shares
421 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Advances in Skin Cancer Therapies Fueling Market GrowthResearch collaborations between biotechnology firms and healthcare institutions are increasing.Joint innovation efforts are accelerating therapeutic advancements. The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX Million by 2031. The market reflects strong clinical demand driven by...0 Comments 0 Shares 592 Views 0 Reviews
-
Advances in Skin Cancer Therapies Fueling Market GrowthResearch collaborations between biotechnology firms and healthcare institutions are increasing.Joint innovation efforts are accelerating therapeutic advancements. The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX Million by 2031. The market reflects strong clinical demand driven by...0 Comments 0 Shares 607 Views 0 Reviews
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 207 Views 0 Reviews
-
Chemotherapy Market to Reach USD 20.2 Billion by 2033, Growing at 7.1% CAGRThe global chemotherapy market size was valued at USD 10.61 billion in 2024 and is projected to grow from USD 11.52 billion in 2025 to USD 20.2 billion by 2033, growing at a CAGR of 7.1% during the forecast period (2025-2033). According to Straits Research, this report provides a clear understanding of the Chemotherapy Market by analyzing its overall structure, key dynamics, and...0 Comments 0 Shares 594 Views 0 Reviews
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comments 0 Shares 112 Views 0 Reviews
-
Emerging Therapies Transforming the Sarcoma Drugs IndustryImmunotherapy is emerging as a promising treatment approach.Checkpoint inhibitors are being evaluated for sarcoma cases.Combination therapies are improving patient survival outcomes. The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...0 Comments 0 Shares 843 Views 0 Reviews
-
Future of Radiation Protection: Anti-Radiation Drugs Market InsightsThe market is gaining traction as cancer treatment protocols increasingly incorporate radiation therapy. The need to reduce therapy-related toxicity is boosting adoption of anti-radiation drugs. Continuous innovation is expanding therapeutic applications. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Comments 0 Shares 507 Views 0 Reviews
-
Global Bladder Cancer Market Trends Shaping Treatment FutureThe rising aging population remains a key growth factor for the market.Older adults face higher risks of bladder cancer, increasing treatment demand.Healthcare systems are responding with improved therapeutic and diagnostic infrastructure. 5. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...0 Comments 0 Shares 743 Views 0 Reviews
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Comments 0 Shares 150 Views 0 Reviews
-
Global CT Simulators Market Growing at 5.4% CAGR Through 2034According to a new report from Intel Market Research, the global Computed Tomography (CT) Simulators market was valued at USD 1.02 billion in 2025 and is projected to reach USD 1.65 billion by 2034, growing at a CAGR of 5.4% during the forecast period (2025–2034). This growth is propelled by the rising global cancer burden, technological advancements in image-guided radiotherapy (IGRT),...0 Comments 0 Shares 244 Views 0 Reviews
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comments 0 Shares 120 Views 0 Reviews
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Comments 0 Shares 295 Views 0 Reviews
More Results